TABLE 2

Clinical characteristics of study subjects in the case-control association study

VariableType 2 diabetic patientsControl subjects
n395298
Sex (M/F)171/224140/158
Age (years)61 ± 1060 ± 9
BMI (kg/m2)29.2 ± 4.626.7 ± 3.9
WHR (males)0.99 ± 0.060.95 ± 0.06
WHR (females)0.89 ± 0.070.83 ± 0.06
Fasting plasma glucose (mmol/l)10.0 ± 3.45.5 ± 0.6
Fasting serum insulin (mU/l)18.2 ± 22.98.3 ± 4.8
HOMA8.9 ± 14.32.1 ± 1.3
Fasting FFA (μmol/l)841 ± 300664 ± 241
Insulin treatment (%)23.3
  • Data are means ± SD. The study material is composed of two subgroups, Botnia I and Botnia II. Data on FFA levels were available for a subset of individuals (212 control subjects [102 men, 110 women] and 274 type 2 diabetic patients [113 men, 161 women]). (See research design and methods for description of groups.)